Genomics Shapes the Future of Laboratory Medicine
Friday, September 21, 2012
“(Pathologists) are the healthcare professionals who diagnose cancer and provide staging and grading information to guide treatment. For the best possible patient care, we need to be at the forefront as genomic technologies enter the clinical arena and learn how to integrate this testing into our current practice.”
—Richard L. Haspel, MD, FASCP
As genomic testing is rapidly changing patient care, pathologists need to take a leading role.
“We have the expertise to ensure accurate testing and interpret the results,” said Richard L. Haspel, MD, FASCP, Assistant Professor of Pathology at Harvard Medical School, Boston, and Director of the Laboratory Medicine Residency Training Program at Beth Israel Deaconess Medical Center, Boston. “We are the healthcare professionals who diagnose cancer and provide staging and grading information to guide treatment. For the best possible patient care, we need to be at the forefront as genomic technologies enter the clinical arena and learn how to integrate this testing into our current practice.”
Dr. Haspel will take part in a session titled, “Genomic Testing: What Pathologists Need to Know,” at the 2012 ASCP Annual Meeting, Oct. 31–Nov. 3, in Boston. This session, a joint collaboration of the American Society for Clinical Pathology (ASCP), the American Society for Investigative Pathology (ASIP), and the Association for Molecular Pathology (AMP), will focus on practical issues for the pathologist. The faculty will use both lectures covering current methods in genomic testing and evidence for clinical benefit, and interactive approaches related to interpreting genomic data.
The genomics session for the 2012 ASCP Annual Meeting has been developed by members of the Training Residents in Genomics (TRIG) Working Group. Established in 2010, this group made up of experts in molecular pathology, medical education, and genetic counseling was formed to provide pathology education resources. One of the TRIG Working Group’s first goals was to create four lectures that can be used by training programs to supplement an already existing molecular pathology curriculum for residents (available at www.pathologytraining.org/trig_lecture.htm).
“This session is not just for residents,” Dr. Haspel said. “We’re incorporating some materials created by the TRIG Working Group, but the information provided will be useful to all ASCP Annual Meeting attendees who want to start developing the skills needed to incorporate genomic pathology into their practice.”
During the session, Dr. Haspel will present an introduction to core concepts in genomics, including the basics of the technology. Mark Sobel, MD, PhD, a molecular pathologist and Intersociety Council for Pathology Information (ICPI) Executive Officer, will then describe how genomic testing can be applied to clinical care.
Using actual genomic data sets, Mark Boguski, MD, PhD, Assistant Professor of Pathology at the Center for Biomedical Informatics at Harvard Medical School, and a member of the Department of Pathology at Beth Israel Deaconess Medical Center, Boston, will take attendees through the process of data collection, annotation, and interpretation. Molecular pathologist Laura J. Tafe, MD, FASCP, Assistant Professor of Pathology at Dartmouth Hitchcock Medical Center, Lebanon, N.H., will lead a panel discussion on the future of genomic pathology.
“We are hoping that those attending this session will develop an appreciation of the benefits and limitations of genomic testing as well as an understanding of the skills needed to evaluate clinical applications of genomic technology and interpret test results,” Dr. Haspel said.
The ASCP Annual Meeting session on genomics will be held at 8 a.m. on Nov. 1, 2012. For more information about our roster of programs and to register, please visit www.ascp.org/2012AnnualMeeting. The 2012 Annual Meeting App is now available for iPhone and Android devices. For iOS (iPhone, iPad), click here. For Android, click here.